Monoclonal Antibody Treatment Removes Cancer in Every Patient

Larry A. Law

A cancer trial published in the New England Journal of Medicine on June 5, 2022 is the first ever to report the removal of the disease in every single patient. Twelve rectal cancer patients were given dostarlimab (Jemperli), a monoclonal antibody, every 3 weeks for 6 months. Doctors could not find any evidence of tumors after treatment; patients continued to show no signs of cancer during check-ups ranging in the subsequent 6-25 month period. No surgery, radiation or chemotherapy was ever administered. No adverse events of grade 3 or higher were ever reported. 

Rectal Cancer Statistics

This specific cancer is officially known as mismatch repair–deficient, locally-advanced rectal cancer. 62% of the patients were women and the median age was 54.  Statistically, the incidence of rectal cancer is rising among young women of childbearing age. One-third of the 145,000 cases of colorectal cancers diagnosed each year are found in the rectum, so this ground-breaking treatment represents a huge triumph.

COVID-19 Treatments

Monoclonal antibodies were also important in COVID-19 treatment. Studies proved they reduced the risk of hospitalization and death in the 60-85 percent range. The State of Florida was using sotrovimab as their monoclonal antibody treatment with great success. However, President Biden's administration removed its Emergency Use Authorization (EUA) in January 2022. They did this because some scientists had written a handful of preprints (non-peer-reviewed papers) suggesting that sotrovimab would not work on the omicron variant. The manufacturers (GlaxoSmithKline-GSK) and Vir Biotechnology rushed to prove their product would indeed work against Omicron and that the science utilized in the preprints was not clinically valid. Unfortunately, the manufacturers lost their fight to retain their monoclonal antibody treatment EUA. As a result, the Food and Drug Administration (FDA) expanded remdesivir's authorization and monoclonal treatment for COVID was effectively nixed. It was really no surprise as remdesivir is Dr. Fauci's personal favorite drug despite the horrendous side effects associated with it (which he chooses to ignore). 

Monoclonal Antibody Treatment a Victim to Politics

Florida Governor Ron DeSantis tweeted President Joe Biden with "Floridians have benefited from the state's treatment sites and their access to treatment shouldn't be denied based on the whims of a floundering president." Of course, this didn't win any friends in Washington D.C. so monoclonal antibody treatment remained off limits to Florida and they had to close their treatment sites. In an interview with Joe Rogan, Dr. Peter McCullough stated that he thought there was "an intentional, very comprehensive suppression" of early treatments to "promote fear, suffering, isolation, hospitalizations, and death." 

Bottom Line

So, monoclonal antibody treatment showed great promise during COVID-19, but Dr. Fauci shut the door to this effective treatment so he could promote the pharmaceutical money-making vaccinations. Like hydroxychloroquine, ivermectin, and zinc, monoclonal antibody treatment remains a valuable COVID treatment approach despite the mainstream media collusion with Big Pharma. It's satisfying to see how successful the monoclonal treatment was in the rectal cancer trials; the hope is now that the politics of the moment settle in the dust, we will be able to see clearly the power of therapeutic treatment approaches to COVID. 

If you are interested in reading a great book on vaccine science and myth, I can highly recommend one that is written in a way to help parents make intelligent decisions about childhood vaccines. Since the COVID shots were recently approved for children 6 months and older as part of the Centers for Disease Control (CDC) Recommended Immunization Schedule for children, this book is an easily read resource to reference when meeting with your doctor. The book is Turtles All the Way Down, is very insightful, and has impeccable science.